5-Dec-2025 9:07 AM CST - Morningstar Ginkgo Bioworks Shares Rise After 4-Year, $47 Million Contract Ginkgo Bioworks shares were 6% higher, at $9.76, after the company said it has been awarded a four-year contract, worth up to $47 million, by the Environmental Molecular Sciences Laboratory at Pacific Northwest National Laboratory.
20-Nov-2025 10:27 AM CST - Seeking Alpha Ginkgo Bioworks: Scaling Science, Not Revenue Ginkgo Bioworks continues to face a weak demand environment, which has contributed to a lack of growth in recent years. Learn more about DNA stock here.
11-Nov-2025 12:15 AM CST - Seeking Alpha Ginkgo Bioworks: Not There Yet Get the latest insights on Ginkgo Bioworks (DNA) stock: missed Q3 targets, revenue slowdown, rising losses, and investor dilution.
9-Nov-2025 11:51 AM CST - Yahoo Finance How Recent Developments Are Shaping the Ginkgo Bioworks Investment Story Ginkgo Bioworks Holdings has recently seen its fair value price target reaffirmed at $12.00 per share. The discount rate has increased from 8.53% to 9.26% to account for a slightly higher risk profile.
10-Oct-2025 4:40 AM CST - Reuters U.S loans $1.1 bln to Ginkgo Bioworks for pandemic effort The U.S. government has agreed to loan privately-held biotechnology firm Ginkgo Bioworks $1.1 billion for COVID-19 testing and the production of raw materials for therapies that may help address future pandemics.
10-Oct-2025 1:30 AM CST - Yahoo Finance Looking at the Narrative for Ginkgo Bioworks After Recent Analyst and Strategy Updates Ginkgo Bioworks Holdings has seen its consensus analyst price target rise from $11.33 per share to $12.00 per share. This reflects a modest but noteworthy vote of confidence from the market. The upward revision comes amid shifting expectations following recent performance updates,
5-Dec-2025 9:07 AM CST - Morningstar Ginkgo Bioworks Shares Rise After 4-Year, $47 Million Contract Ginkgo Bioworks shares were 6% higher, at $9.76, after the company said it has been awarded a four-year contract, worth up to $47 million, by the Environmental Molecular Sciences Laboratory at Pacific Northwest National Laboratory.
20-Nov-2025 10:27 AM CST - Seeking Alpha Ginkgo Bioworks: Scaling Science, Not Revenue Ginkgo Bioworks continues to face a weak demand environment, which has contributed to a lack of growth in recent years. Learn more about DNA stock here.
11-Nov-2025 12:15 AM CST - Seeking Alpha Ginkgo Bioworks: Not There Yet Get the latest insights on Ginkgo Bioworks (DNA) stock: missed Q3 targets, revenue slowdown, rising losses, and investor dilution.
9-Nov-2025 11:51 AM CST - Yahoo Finance How Recent Developments Are Shaping the Ginkgo Bioworks Investment Story Ginkgo Bioworks Holdings has recently seen its fair value price target reaffirmed at $12.00 per share. The discount rate has increased from 8.53% to 9.26% to account for a slightly higher risk profile.
10-Oct-2025 4:40 AM CST - Reuters U.S loans $1.1 bln to Ginkgo Bioworks for pandemic effort The U.S. government has agreed to loan privately-held biotechnology firm Ginkgo Bioworks $1.1 billion for COVID-19 testing and the production of raw materials for therapies that may help address future pandemics.
10-Oct-2025 1:30 AM CST - Yahoo Finance Looking at the Narrative for Ginkgo Bioworks After Recent Analyst and Strategy Updates Ginkgo Bioworks Holdings has seen its consensus analyst price target rise from $11.33 per share to $12.00 per share. This reflects a modest but noteworthy vote of confidence from the market. The upward revision comes amid shifting expectations following recent performance updates,
